Last reviewed · How we verify
NCT04455984
Multimodality Treatment Including Curative Resection of Advanced NSCLC
trial testing Date collection in Advanced Non-small-cell Lung Cancer in 190 participants. Status unknown.
1 August 2020
Quick facts
| Lead sponsor | Medical University of Vienna |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 190 |
| Start date | 1 May 2017 |
| Primary completion | 1 August 2020 |
| Estimated completion | 1 August 2020 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Date collection
Conditions studied
- Advanced Non-small-cell Lung Cancer — all drugs for Advanced Non-small-cell Lung Cancer →
Sponsor
Medical University of Vienna
Who can join
18 and older, any sex, with Advanced Non-small-cell Lung Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study retrospectively evaluates clinical parameters and outcome of patients with advanced stage non-small cell lung cancer treated with neoadjuvant therapy followed by curative-intent surgery at the Divison of Thoracic Surgery at the Medical University of Vienna
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study.
Sinn K, Mosleh B, Steindl A, Zoechbauer-Mueller S, et al · · 2022 · cited 10× · PMID 35397435 · DOI 10.1016/j.esmoop.2022.100466
Verify or expand the search:
- PubMed search for NCT04455984
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Date collection
Trials testing the same drug.
- NCT04211077 — Suicidal Risk Factors Associated With Opioid Analgesics Use · completed
- NCT03162380 — Occupational Stress and Bipolar Disorder · completed
Other recruiting trials for Advanced Non-small-cell Lung Cancer
Currently open trials in the same condition.
- NCT05904379 — AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer · Phase 1, PHASE2 · active not recruiting
- NCT05499390 — AK112 in Advanced Non-Small Cell Lung Cancer · Phase 3 · active not recruiting
Other Medical University of Vienna trials
Trials by the same sponsor.
- NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
- NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
- NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
- NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
- NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04455984 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
- Last refreshed: 7 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04455984.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing